CN Patent

CN101653422A — 利培酮缓释微球、其制备方法和用途

Assigned to Nanjing Lvye Pharma Co Ltd · Expires 2010-02-24 · 16y expired

What this patent protects

本发明提供了一种利培酮缓释微球、其制备方法和用途。所述微球含有利培酮或9－羟基利培酮或其盐和未封端的丙交酯－乙交酯共聚物。本发明所提供的利培酮缓释微球具有更高的载药量，体内无突释现象、血药浓度平稳，且无药物释放停滞期，可以大大减少患者的给药频率，减少每次给药体积，提高了患者的顺应性，减少不良反应的发生。

USPTO Abstract

本发明提供了一种利培酮缓释微球、其制备方法和用途。所述微球含有利培酮或9－羟基利培酮或其盐和未封端的丙交酯－乙交酯共聚物。本发明所提供的利培酮缓释微球具有更高的载药量，体内无突释现象、血药浓度平稳，且无药物释放停滞期，可以大大减少患者的给药频率，减少每次给药体积，提高了患者的顺应性，减少不良反应的发生。

Drugs covered by this patent

Patent Metadata

Patent number
CN101653422A
Jurisdiction
CN
Classification
—
Expires
2010-02-24
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Lvye Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.